Can Keppra 2g Be Administered as IV Push?
Yes, a 2-gram dose of Keppra (levetiracetam) can be safely administered as an IV push, and this method significantly reduces time to administration compared to the standard 15-minute infusion without increasing adverse events.
Administration Method
The FDA-approved labeling specifies that Keppra injection should be administered as a 15-minute IV infusion after dilution in 100 mL of compatible diluent 1. However, emerging evidence strongly supports IV push administration as a safe and more efficient alternative.
IV Push Administration Details:
- Rate: Administer undiluted over 2-5 minutes 2, 3
- Dilution: Can be given undiluted (100 mg/mL concentration) 3, 4
- Access: Safe via peripheral IV line 5, 3
- Doses studied: Up to 4500 mg have been safely administered via IV push 3, 6
Evidence Supporting IV Push
Multiple retrospective studies demonstrate that IV push levetiracetam:
- Reduces time to administration from 80 minutes (IVPB) to 28 minutes (IVP) 2 and from 55 minutes to 23.5 minutes in another study 4
- Decreases benzodiazepine use during the interim period (2% vs 13%, p=0.042) 2
- Shows no increase in adverse events compared to standard infusion 2, 7, 4
In a study of 953 patients receiving 8,561 undiluted IV push doses (42.9% >1000 mg), only 4 adverse events were potentially related to administration—all limited to minor local injection site reactions 3.
Safety Profile
Adverse events are rare and comparable between IV push and infusion:
- Hypotension: 5.2-9.2% (often confounded by concurrent medications) 4, 6
- Bradycardia: 1.5-3.2% 4
- Sedation: 19.3-27.9% 4
- Injection site reactions: <1% 3, 4
The higher rate of hypotension (9.2%) in one study of high-dose (≥3g) IV push was confounded by 80% of affected patients being on concurrent medications with hemodynamic effects 6.
Clinical Context
For status epilepticus, current guidelines recommend levetiracetam as a second-line agent after benzodiazepines, with doses of 30-60 mg/kg (typically 2000-4500 mg in adults) 8. The ESETT trial demonstrated that levetiracetam, fosphenytoin, and valproate have similar efficacy (~47% seizure cessation) when given after benzodiazepine failure 8.
IV push administration is particularly advantageous in seizure emergencies where rapid drug delivery is critical. One study showed that in status epilepticus patients, IV push was associated with reduced ICU admissions compared to standard infusion 7.
Practical Recommendations
For a 2-gram loading dose:
- Administer undiluted (two 5 mL vials of 500 mg/5 mL) over 2-5 minutes
- Can use peripheral IV access
- Monitor blood pressure and heart rate during and immediately after administration
- Be aware that patients on concurrent sedatives or vasodilators may have increased hypotension risk
Important Caveats:
- While FDA labeling requires 15-minute infusion, multiple institutional protocols have safely adopted IV push administration 2, 3, 4
- Hemodynamic monitoring is essential, particularly in patients receiving concurrent medications affecting blood pressure
- The evidence base consists primarily of retrospective studies; prospective randomized trials are needed 7, 5
Bottom line: IV push administration of 2g levetiracetam is safe, well-tolerated, and clinically superior to standard infusion in time-sensitive situations like active seizures, with appropriate monitoring.